Primary |
Attention Deficit/hyperactivity Disorder |
88.9% |
Bipolar Disorder |
3.7% |
Chronic Fatigue Syndrome |
3.7% |
Disturbance In Attention |
3.7% |
|
Product Substitution Issue |
23.1% |
Drug Ineffective |
7.7% |
Abnormal Behaviour |
3.8% |
Aggression |
3.8% |
Condition Aggravated |
3.8% |
Depression |
3.8% |
Drug Effect Decreased |
3.8% |
Dyskinesia |
3.8% |
Dyspnoea |
3.8% |
Generalised Anxiety Disorder |
3.8% |
Hallucination, Auditory |
3.8% |
Insomnia |
3.8% |
Medication Error |
3.8% |
No Adverse Event |
3.8% |
Paranoia |
3.8% |
Physical Abuse |
3.8% |
Product Formulation Issue |
3.8% |
Pruritus |
3.8% |
Psychotic Disorder |
3.8% |
Reaction To Drug Excipients |
3.8% |
|
Secondary |
Product Used For Unknown Indication |
31.9% |
Attention Deficit/hyperactivity Disorder |
12.0% |
Depression |
9.1% |
Pain |
7.5% |
Anxiety |
6.5% |
Drug Abuse |
4.5% |
Mental Disorder |
3.5% |
Sleep Disorder |
2.8% |
Bipolar Disorder |
2.6% |
Multiple Sclerosis |
2.2% |
Muscle Spasms |
2.2% |
Back Pain |
1.8% |
Mood Swings |
1.8% |
Abdominal Discomfort |
1.6% |
Anxiety Disorder |
1.6% |
Blood Cholesterol Increased |
1.6% |
Drug Dependence |
1.6% |
Headache |
1.6% |
Hysterectomy |
1.6% |
Muscle Spasticity |
1.6% |
|
Anxiety |
9.1% |
Drug Effect Decreased |
7.3% |
Drug Ineffective |
7.3% |
Headache |
7.3% |
Dizziness |
5.5% |
Drug Withdrawal Syndrome |
5.5% |
Dyspepsia |
5.5% |
Dystonia |
5.5% |
Tremor |
5.5% |
Weight Increased |
5.5% |
Abnormal Dreams |
3.6% |
Anger |
3.6% |
Blood Glucose Abnormal |
3.6% |
Crying |
3.6% |
Drug Dose Omission |
3.6% |
Drug Prescribing Error |
3.6% |
Dyskinesia |
3.6% |
Dyspnoea |
3.6% |
Feeling Abnormal |
3.6% |
Hyperhidrosis |
3.6% |
|
Concomitant |
Product Used For Unknown Indication |
21.7% |
Attention Deficit/hyperactivity Disorder |
13.9% |
Depression |
10.8% |
Anxiety |
6.6% |
Pain |
6.3% |
Multiple Sclerosis |
5.6% |
Contraception |
5.3% |
Bipolar Disorder |
4.2% |
Insomnia |
2.5% |
Rheumatoid Arthritis |
2.5% |
Acne |
2.5% |
Hypertension |
2.3% |
Premenstrual Syndrome |
2.2% |
Gastrooesophageal Reflux Disease |
2.1% |
Sleep Disorder |
2.1% |
Hepatitis C |
2.0% |
Back Pain |
1.9% |
Migraine |
1.9% |
Intervertebral Disc Protrusion |
1.8% |
Crohn's Disease |
1.7% |
|
Pain |
9.1% |
Anxiety |
7.5% |
Fatigue |
7.5% |
Drug Ineffective |
6.4% |
Deep Vein Thrombosis |
6.0% |
Menstruation Irregular |
6.0% |
Vomiting |
6.0% |
Depression |
5.7% |
Injury |
5.3% |
Arthralgia |
4.9% |
Nausea |
4.9% |
Cholecystitis Chronic |
4.5% |
Pulmonary Embolism |
4.2% |
Weight Increased |
4.2% |
Emotional Distress |
3.8% |
Drug Dose Omission |
3.0% |
Migraine |
3.0% |
Convulsion |
2.6% |
Dizziness |
2.6% |
Pain In Extremity |
2.6% |
|
Interacting |
Acne |
40.0% |
Attention Deficit/hyperactivity Disorder |
20.0% |
Dyspepsia |
20.0% |
Gastrooesophageal Reflux Disease |
20.0% |
|
Drug Interaction |
50.0% |
Drug Effect Decreased |
25.0% |
Paraesthesia |
25.0% |
|